...
首页> 外文期刊>The Journal of molecular diagnostics: JMD >Polymer-Based Precipitation of Extracellular Vesicular miRNAs from Serum Improve Gastric Cancer miRNA Biomarker Performance
【24h】

Polymer-Based Precipitation of Extracellular Vesicular miRNAs from Serum Improve Gastric Cancer miRNA Biomarker Performance

机译:来自血清细胞外囊泡miRNA的基于聚合物的沉淀,改善了胃癌mioMarker性能

获取原文
获取原文并翻译 | 示例
           

摘要

Circulating miRNAs are promising liquid biopsy biomarkers for noninvasive cancer detection. However, detection of subtle, but meaningful differences in circulating miRNA quantities between diseased and healthy samples remains a key challenge in clinical settings because biomarker signal/noise ratios are often low. Because extracellular vesicles (EVs) are key sources of circulating miRNAs in serum, it was hypothesized that isolating EVs would enrich miRNA biomarkers, leading to enhanced diagnostic ability and improved biomarker performance. This research assessed the performance of EV-miRNAs against serum miRNAs as biomarkers for gastric cancer (GC). It was first determined that polymer-based precipitation (PBP) gave the highest EV-miRNA recovery when compared with ultracentrifugation, column affinity, peptide affinity, and immunobead affinity EV purification. Four PBP reagents were used to isolate EV-miRNAs from 15 GC and 15 healthy controls and 133 GC-related miRNAs were profiled from EV fractions and total serum using real-time quantitative PCR. A PBP reagent that generated the most EV-miRNA biomarkers was selected and used to validate 11 EV-miRNAs in an independent set of 20 GC and 20 controls. Eight of these EV-miRNA biomarkers were found to give better GC detection accuracy (area under the curve, approximately 0.8). Overall, data suggest that EV miRNAs can improve GC detection performance compared with serum miRNAs and led to the identification of eight EV-miRNAs as potential noninvasive biomarkers for GC.
机译:循环miRNA是有前途的液检生物标志物,用于非侵入性癌症检测。然而,检测患病和健康样品之间循环miRNA量的微妙,但有意义的差异仍然是临床环境中的关键挑战,因为生物标志物信号/噪声比通常很低。由于细胞外囊泡(EVS)是血清中循环miRNA的关键来源,因此假设分离的EVS是富集MirNA生物标志物,导致诊断能力提高和改善的生物标志物性能。该研究评估了EV-MIRNA对血清MiRNA作为胃癌(GC)的生物标志物的表现。首先确定基于聚合物的沉淀(PBP)在与超速离心,塔亲和力,肽亲和力和免疫型亲和力EV纯化相比时给出了最高的EV-miRNA恢复。使用四种PBP试剂将EV-miRNA分离15gc,15个健康对照,并使用实时定量PCR从EV级分和总血清分析133个与GC相关的miRNA。选择产生大多数EV-miRNA生物标志物的PBP试剂并用于在独立的20GC和20个对照组中验证11eV-miRNA。发现八个这些EV-miRNA生物标志物得到更好的GC检测精度(曲线下的区域,约为0.8)。总体而言,数据表明,与血清miRNA相比,EV miRNA可以提高GC检测性能,并导致八个EV-miRNA作为GC的潜在非侵入性生物标志物。

著录项

  • 来源
  • 作者单位

    A STAR Bioproc Technol Inst Anim &

    Cell Technol Grp 3 Singapore Singapore;

    A STAR Bioproc Technol Inst Anim &

    Cell Technol Grp 3 Singapore Singapore;

    A STAR Bioproc Technol Inst Anim &

    Cell Technol Grp 3 Singapore Singapore;

    Natl Univ Singapore Yong Loo Lin Sch Med Dept Biochem Singapore Singapore;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 临床医学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号